Peptides to Overcome the Limitations of Current Anticancer and Antimicrobial Nanotherapies
Biomedical research devotes a huge effort to the development of efficient non-viral nanovectors (NV) to improve the effectiveness of standard therapies. NVs should be stable, sustainable and biocompatible and enable controlled and targeted delivery of drugs. With the aim to foster the advancements o...
| الحاوية / القاعدة: | Pharmaceutics |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
MDPI AG
2022-06-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/1999-4923/14/6/1235 |